In a study, a team of UCLA investigators detail a deep-learning model pre-trained on 2D scans that accurately predicts ...

The award from the National Institutes of Health will enable a team of researchers to investigate Alzheimer and Parkinson ...

Aldeyra Therapeutics has resubmitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for topical ...

The donation will support the development of the Artificial Intelligence Innovation Center, a collaborative hub with a focus ...

Because the inner retinal function is thought to affect the emmetropization process, authors suggested that caffeine may be ...

CVD, an AI diagnostic solution that autonomously assesses future cardiovascular disease risk using a retina scan.

Johnson & Johnson is expanding the launch of its presbyopia-correcting intraocular lense (IOL) , TECNIS Odyssey, in the US. The TECNIS Odyssey IOL is a new full vision range IOL, built on the TECNIS ...

Adam S. Wenick, MD, PhD, chaired a symposium on geographic atrophy (GA) at EyeCon 2024, focusing on the diagnosis, monitoring ...

In a study, a team of Chinese researchers looked at the mechanisms behind the development of EI and explored effective ...

Proviant Therapeutics announced the first patients have been enrolled in CLARITY, its phase 3 study ( NCT06431373) evaluating ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

During a presentation at EyeCon 2024, Jennifer Loh, MD, of Loh Ophthalmology Associates in Miami, Florida, discussed advances ...